ZYNE - Zynerba Pharmaceuticals, Inc.
| Previous Close | 5.75 |
| Open | 5.80 |
| Bid | 5.71 x 1100 |
| Ask | 5.72 x 1200 |
| Day's Range | 5.68 - 5.94 |
| 52 Week Range | 2.75 - 16.47 |
| Volume | 243,812 |
| Avg. Volume | 650,690 |
| Market Cap | 132M |
| Beta (5Y Monthly) | 4.61 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.46 |
| Earnings Date | Nov 6, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21.50 |
- GlobeNewswire
iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE)- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Actions
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.
- Newsfile
Zynerba Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm
New York, New York--(Newsfile Corp. - December 12, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) ("Zynerba" or the "Company") of the December 23, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi logoIf you invested in Zynerba stock or options between March 11, 2019 ...
- GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline– ZYNE
Pomerantz LLP announces that a class action lawsuit has been filed against Zynerba Pharmaceuticals, Inc. (“Zynerba” or the “Company”) (NASDAQ: ZYNE) and certain of its officers. The class action, filed in United States District Court, Eastern District of Pennsylvania, and docketed under 19-cv-04959, is on behalf of a class consisting of investors who purchased or otherwise Zynerba securities between March 11, 2019, and September 17, 2019, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- GlobeNewswire
ZYNE DEADLINE: Zhang Investor Law Reminds Investors of December 23 Deadline in Securities Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. – ZYNE
Zhang Investor Law announces a securities class action lawsuit on behalf of shareholders who bought shares of Zynerba Pharmaceuticals, Inc. (ZYNE) between March 11, 2019 and September 17, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court no later than December 23, 2019. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
- PR Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Infosys, Zynerba, iRobot, and Zendesk and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that class action lawsuits have been commenced on behalf of stockholders of Infosys Limited (NYSE: INFY), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), iRobot Corporation (NASDAQ: IRBT), and Zendesk, Inc. (NYSE: ZEN). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
- ACCESSWIRE
iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE)- Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Actions
NEW YORK, NY / ACCESSWIRE / December 9, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review ...
- GlobeNewswire
ZYNE NOTICE: Pawar Law Group Reminds Investors of Deadline in Securities Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc.– ZYNE
Pawar Law Group announces that a class action lawsuit on behalf of shareholders who purchased shares of Zynerba Pharmaceuticals, Inc. (ZYNE) from March 11, 2019 through September 17, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Zynerba Pharmaceuticals, Inc. investors under the federal securities laws. A class action lawsuit has already been filed.
- Zacks
Is Zynerba Pharmaceuticals (ZYNE) Stock Outpacing Its Medical Peers This Year?
Is (ZYNE) Outperforming Other Medical Stocks This Year?
- GlobeNewswire
iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Actions
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.
- Newsfile
Zynerba Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm
New York, New York--(Newsfile Corp. - December 6, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) ("Zynerba" or the "Company") of the December 23, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi logoIf you invested in Zynerba stock or options between March 11, 2019 ...
- GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ADTRAN, Domo, Infosys, and Zynerba and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that class action lawsuits have been commenced on behalf of stockholders of ADTRAN, Inc. (ADTN), Domo, Inc. (DOMO), Infosys Limited (INFY), and Zynerba Pharmaceuticals, Inc. (ZYNE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
- ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline- ZYNE
NEW YORK, NY / ACCESSWIRE / December 4, 2019 / Pomerantz LLP announces that a class action lawsuit has been filed against Zynerba Pharmaceuticals, Inc. ("Zynerba" or the "Company") ...
- GlobeNewswire
INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in Aurora Cannabis, Inc., and Zynerba Pharmaceuticals of Filing Deadlines
Bernstein Liebhard LLP announces that class action complaints have been filed on behalf of shareholders of ACB and ZYNE. If you wish to serve as lead plaintiff, you must move the court by the lead plaintiff deadlines listed below. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
- GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline– ZYNE
Pomerantz LLP announces that a class action lawsuit has been filed against Zynerba Pharmaceuticals, Inc. (“Zynerba” or the “Company”) (NASDAQ: ZYNE) and certain of its officers. The class action, filed in United States District Court, Eastern District of Pennsylvania, and docketed under 19-cv-04959, is on behalf of a class consisting of investors who purchased or otherwise Zynerba securities between March 11, 2019, and September 17, 2019, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- ACCESSWIRE
iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE)- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Actions
NEW YORK, NY / ACCESSWIRE / December 2, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review ...
- GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action - iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE)
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.
- GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Zynerba, iRobot, Zendesk, and PG&E Corporation and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that class action lawsuits have been commenced on behalf of stockholders of Zynerba Pharmaceuticals, Inc. (ZYNE), iRobot Corporation (IRBT), Zendesk, Inc. (ZEN), and PG&E Corporation (PCG). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
- Zacks
Generic Drugmakers Gain as Price-Fixing Probe Nears an End
Shares of generic drugmakers rose on Monday on a possible end to the persistent price-fixing probe.
- ACCESSWIRE
Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action - iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE)
NEW YORK, NY / ACCESSWIRE / November 25, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can ...
